Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Key Takeaway 1: Multidisciplinary Management of HCC

August 15th 2019

Placebo Control Arms Are Deeply Flawed Scientific Tools

August 11th 2019

Particularly in the oncology arena, there are several serious scientific, ethical, and pragmatic concerns associated with ongoing reliance on placebo-controlled studies.

When Physician Becomes Patient, Valuable Lessons Emerge

August 10th 2019

My hopes were to be that rare individual who went through life never having to see the sharp end of a Bard-Parker scalpel. That fantasy is about to come to an abrupt end.

Experts Discuss Highly Anticipated Study Results Across Tumor Types

August 5th 2019

OncLive interviewed experts at the State of the Science Summits in July 2019 on highly anticipated clinical trial results across tumor types.

A Gifted Leader Who Broadened Investigative Work in Oncology

August 3rd 2019

A 2018 Giants of Cancer Care award for Community Outreach, Education, and Cancer Policy, Richard L. Schilsky, MD, built a scaffolding upon which new trials were launched into emerging areas of oncology investigation. His work has led to new standards in cancer care, particularly in breast cancer, and along the way he has furthered the careers of many successful and talented oncologists and investigators.

Fresh Signs of Progress Surface in Geriatric Oncology

August 2nd 2019

Although there has been significant progress in the field of geriatric oncology, experts say there is still a pressing need to increase clinical trial participation by older patients and to improve the predictive value of assessment tools.

Role of PARP Inhibitors in Prostate Cancer

July 31st 2019

Considerations for Genetic Testing in Prostate Cancer

July 31st 2019

Sequencing in Nonmetastatic and Metastatic CRPC

July 31st 2019

Patient Selection for Radium-223 in mCRPC

July 31st 2019

Reducing Risk of Fracture in Metastatic CRPC

July 31st 2019

AR-V7 as a Predictive Biomarker in Metastatic CRPC

July 31st 2019

Frontline Therapy in Newly Diagnosed Metastatic HSPC

July 31st 2019

Historical Perspectives on ADT in Prostate Cancer

July 31st 2019

ASCO 2019: Novel Agents in Metastatic CSPC

July 31st 2019

Expanding Treatment Options for Metastatic CSPC

July 31st 2019

Cardiac Toxicity in Nonmetastatic CRPC

July 31st 2019

Management of Adverse Events in M0 CRPC

July 31st 2019

Practical Advice on Follow-Up for Patients with M0 CRPC

July 31st 2019

Benefits of Newly Approved Drugs for M0 CRPC

July 31st 2019